The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Methyl-4-amine-5-((4-(((5-(2-chloro-4-nitrophenyl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyrimidine ID: ALA3775433
PubChem CID: 127034129
Max Phase: Preclinical
Molecular Formula: C17H14ClN9O3S
Molecular Weight: 459.88
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncc(Cn2cc(CSc3nnc(-c4ccc([N+](=O)[O-])cc4Cl)o3)nn2)c(N)n1
Standard InChI: InChI=1S/C17H14ClN9O3S/c1-9-20-5-10(15(19)21-9)6-26-7-11(22-25-26)8-31-17-24-23-16(30-17)13-3-2-12(27(28)29)4-14(13)18/h2-5,7H,6,8H2,1H3,(H2,19,20,21)
Standard InChI Key: IGZDPQDQRVTLBQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 -1.4978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 -0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2526 -1.3618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.2524 -0.2436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4979 1.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0317 0.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0997 2.4249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2115 3.6347 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.8144 5.0092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0510 6.2856 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.0508 7.4038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4233 6.7985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.2717 5.3062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7337 8.8707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3483 9.4327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1425 10.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3264 11.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7160 11.2749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9218 9.7891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4014 8.6955 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-5.1235 13.3267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.0717 14.0622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0126 13.7804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
6 8 1 0
5 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 2 0
19 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
23 28 1 0
29 30 2 0
29 31 1 0
25 29 1 0
M CHG 2 29 1 31 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 459.88Molecular Weight (Monoisotopic): 459.0629AlogP: 2.91#Rotatable Bonds: 7Polar Surface Area: 164.57Molecular Species: NEUTRALHBA: 12HBD: 1#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.97CX LogP: 2.34CX LogD: 2.33Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.25Np Likeness Score: -2.37
References 1. He H, Wang W, Zhou Y, Xia Q, Ren Y, Feng J, Peng H, He H, Feng L.. (2016) Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors., 24 (8): [PMID:26972920 ] [10.1016/j.bmc.2016.03.011 ]